New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy
Steve S. Chung, Kristen Kelly, Courtney Schusse
J Epilepsy Res. 2011;1(2):35-46. Published online 2011 Dec 30 DOI: https://doi.org/10.14581/jer.11008
Citations to this article as recorded by 
Study of the metabolic stability profiles of perampanel, rufinamide and stiripentol and prediction of drug interactions using HepaRG cells as an in vitro human model
Sara Meirinho, Márcio Rodrigues, Ana Fortuna, Amílcar Falcão, Gilberto Alves
Toxicology in Vitro.2022; 82: 105389. CrossRef
Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review
Sara Meirinho, Márcio Rodrigues, Ana Fortuna, Amílcar Falcão, Gilberto Alves
Journal of Pharmaceutical Analysis.2021; 11(4): 405. CrossRef
The Effect of Anti-seizure Medications on the Propagation of Epileptic Activity: A Review
Mohamed Khateb, Noam Bosak, Moshe Herskovitz
Frontiers in Neurology.2021;[Epub] CrossRef
Perampanel in brain tumor and SMART-syndrome related epilepsy – A single institutional experience
Johanna Heugenhauser, Sarah Iglseder, Armin Muigg, Johannes Kerschbaumer, Guenther Stockhammer, Martha Nowosielski, Iris Unterberger
Journal of the Neurological Sciences.2021; 423: 117386. CrossRef
Effect of Lacosamide and Ethosuximide Chronic Treatment on Neural Precursor Cells and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice
Aleksandra Szewczyk, Mirosław Zagaja, Joanna Szala-Rycaj, Maciej Maj, Marta Andres-Mach
Brain Sciences.2021; 11(8): 1014. CrossRef
Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages
Tatiana N. Zamay, Galina S. Zamay, Natalia A. Shnayder, Diana V. Dmitrenko, Sergey S. Zamay, Victoria Yushchenko, Olga S. Kolovskaya, Vanessa Susevski, Maxim V. Berezovski, Anna S. Kichkailo
Molecular Therapy - Nucleic Acids.2020; 19: 157. CrossRef
Dietary therapy is not the best option for refractory nonsurgical epilepsy
María Magdalena Vaccarezza, Walter Horacio Silva
Epilepsia.2015; 56(9): 1330. CrossRef
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Investigation.2014; 4(9): 839. CrossRef